Prosthetic joint infections;Infections de prothèse articulaire

Medecine et Maladies Infectieuses

Volumn 33, Issue 5, 2003, Pages 231-239

  Bernard, L ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Osteitis; Prosthetic joint infection

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; FUSIDIC ACID; GLYCOPEPTIDE; IMIPENEM; METRONIDAZOLE; OFLOXACIN; OXACILLIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTHRODESIS; ARTHROPLASTY; DEBRIDEMENT; DRUG INDUCED DISEASE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; IMPLANT; INFECTIOUS ARTHRITIS; JOINT PROSTHESIS; LENGTH OF STAY; LONG TERM CARE; PATIENT CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; REVIEW; SURGICAL TECHNIQUE; TREATMENT PLANNING;

EID: 0037832574     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(03)00056-8     Document Type: Review

References (48)

1. Hebert CK, Williams RS, Levy RS, Barrack RL. Cost of treating total knee replacement. Clin Orthop 1996;331:140-5.
2. Bengton S. Prosthetic osteomyelitis with special reference to the knee risks, treatement and costs. Ann Med 1993;25(6):523-9.
3. François P, Vaudaux P, Foster TJ, Lew DP. Host-bacteria interactions in foreign body infections. Infect Control Hosp Epidemiol 1996;17:514-20.
4. Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 2001;33(Suppl 2):S94-S106.
5. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms a common cause of persitent infections. Science 1999;284:1318-22.
6. Hussain M, Wilcox MH, White PJ. The slime of coagulase-negative staphylococci biochermistry and relation to adherence. FEMS Microbiol Rev 1993;10:191-207.
7. Proctor RA, Peter G. Small colony variants in staphyloccal infections diagnosstic and therapeutc implantation. Clin Infect Dis 1998;27:419-22.
8. Delmi M, Vaudaux P, Lew DP, Vasey H. Role of fibronectin adhesion to metallic surfaces used as models of orthopaedic devices. J Infect J Orthop Res 1994;12:432-8.
9. Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE. Pathogenesis of foreign body infection description and characteristics of an animal model. J Infect Dis 1982;146:487-97.
10. Archibeck MJ, Jacobs JJ, Black J. Alternate bearing surfaces in joint arthroplasty: biologic considerations. Clin Orthop 2000;379:12-21.
11. An YH, Friedman RJ. Prevention of sepsis in total joint arthroplasty. J Hosp Infect 1996;33:93-108.
12. Hill C, Flamant R, Mazas F, Evrad J. Prophylactic cefazolin versus placebo I, total hip replacement. Lancet 1981;1:795-6.
13. Josefsson G, Gudmundsson G, Kolmert L, Wijkstrom S. Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty: a five year survey of 1688 hips. Clin Orthrop 1990;253:173-8.
14. Conventry MB. Treatment of infections occuring in total hip surgery. Orthop Clin North Am 1975;6:991-1003.
15. Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, Osmon DR. Risk factors for prosthestic joint infections infection: case-control study. Clin Infect Dis 1998;27(5):1247-54.
16. Bernard L, Pron B, Vuagnat A, Gleizes V, Signoret F, Denormandie P, et al. The value of suction drainage fluid culture during aseptic and septic orthopedic surgery a prospective study of 901 patients. Clin Infect Dis 2002;34:46-9.
17. Hanssen AD, Osmon DR, Nelson CL. Prevention of deep periprosthetic joint infection. Instr Course lect 1997;46:555-67.
18. Shih LY, Wu JJ, Yang DJ. Erythocyte sedimentation rate and C-reactive protein values in patients wiyth total hip arthroplasty. Clin Orthrop 1987;225:238-46.
19. Pring DJ, Henderson RG, Keshaarvzian A, Rivett AG, et al. Indiumgranulocyte scanning in the painful prosethetic joint. AJR Am J Roentgenol 1986;147:167-72.
20. Wukich DK, Abreu SH, Callaghan JJ, Van Nostrand D, et al. Diagnosis of infection by preoperative scintigraphy with indium-labeled white blood cells. J Bone Joint Surg Am 1987;69-A:1353-60.
21. Nijhof MW, Oyen W, van Kampen A, Claesens R, et al. Evaluation of infections of the locomotor system with indium-111-labeled human IgG scintigraphy. J Nucl Med 1997;38:1300-5.
22. Yagupsky P, Press J. Use of Isolator 1.5 microbial for culture of synovial fluid from patients with septic arthritis. J Clin Microbiol 1997;35:2410-4.
23. Achanasou NA, Pandey R, De Steiger R, Crook D, Smith PM. Diagnosis of infections by frozen section during revision arthroplasty. J Bone Joint Surg Br 1995;1(77-B):28-35.
24. Della Valle CJ, Bogner E, Desai P, Lonner JH, Adler E, Zuckerman JD, Di Cesare PE. Analysis of frozen sections of intraoperative specimens obtained at the time of reoperation after hip or knee resection arthroplasty for the treatment of infection. J Bone Joint Surg Am 1999;81(5):684-9.
25. Tunney MM, Patrick S, Goman SP, Nixon JR, Anderson N, Davis RI, Hanna D, Ramage G. Improved detection of infection in hip replacements. A currently underestimated problem. J Bone Surg Br 1998;80(4):568-72.
26. Gristina A. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 1987;237:1588-95.
27. Gillespie WJ. Prevention and management of infection after total joint replacement. Clin Infect Dis 1997;25:1310-7.
28. Tuney MM, Patrick S, Curran MD, Ramage G, Hanna JR, Gorman SP, Davis RI, Anderson N. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microspcopy and PCR amplification of bacterial 16S Rrna gene. J Clin Microbiol 1999;37(10):3281-90.
29. Tattevin P, Cremieux AC, Pottier P, Huten D, Carbon C. Prothestic joint infection: when can prothesis salvage be considered? Clin Infect Dis 1999;29:292-5.
30. Segreti J, Nelson JA. Trenholme GM Prolonged suppressive antibiotic therapy for infected orthopedic protheses. Clin Infect Dis 1998;27(4):711-3.
31. Goulet JA, Pellicci PM, Brause BD, Salvati EM. Prolonged suppression of infection in total hip arthoplasty. J Arthroplast 1988;3(2):109-16.
32. Brandt CM, Sistrunk WW, Duffy MC, Hanssen AD, et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prothesis retention. Clin Infect Dis 1997;24:914-9.
33. Fisman DN, Reilly DT, Karchmer AW, Goldie SJ. Clinical effectiveness and costs-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis 2001;32:419-30.
34. Raut VV, Siney PD, Wrobleski BM. One-stage revision of total hip arthroplasty for deep infection. Clin Orthrop 1995;321:202-7.
35. Callaghan JJ, Katz RP, Johnston RC. One-stage revision of the infected hip, A minimum 10-year follow-up study. Clin Orthop 1999;369:139-43.
36. Lieberman JR, Callaway GH, Salvati E, Pellicci PM, Brause BD. Treatment of infected total hip arthroplasty with a two stage reimplantation protocol. Clin Orthrop 1994;301:205-12.
37. Windsor RE, Insall JN, Urs WK, Miller DV, Brause BD. Two stage reimplantation for the salvage of total knee arthroplasty complicated by infection, Further follow-up and refinement of indications. J Bone Joint Surg Am 1990;72:272-8.
38. Nasser S. Prevention and treatment of sepsis in total replacement surgery. Orthop Clin North Am 1992;23:265-77.
39. Nelson CL, Evans RP, Blaha JD, Calhoun J, et al. A comparaison of gentamicin-impregnated PMMAbead implantation to conventional parental antibiotic therapy in infected total hip and knee arthroplasty. J Bone Am 1995;295:96-101.
40. Fitzerald RH. Antibiotic distribution and osteomyelitic bone. Orthrop Clin Orthop 1993;15:537-46.
41. Boseli E, Allaouchiche B. Diffusion osseuse des antibiotiques. Presse Med 1999;28:2265-76.
42. Zimmerdi W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifamapin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial, Foreign Body Infection (FBI) Study Group. JAMA 1998;279(19):1537-41.
43. Bernard L, El-Hajj, Pron A, Gleize V, Signoret F, Denormandie P, Gaillard JL, Perronne C. Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost. J Clin Pharm Ther 2001;26:441-51.
44. Desplaces N, Mamoudy P, Larrouturou, Kitsis MD. Vancomycine en perfusion continue et infections ostéo-articulaires à staphylocoques multirésistants. Méd Mal Infect 1997;27:969-74.
45. Deacon JM, Pagliaro AJ, Zelicof SB, et al. Prophylactic use of antibiotics for procedures after total joint replacement. J Bone Joint Surg 1996(78-A):1755-70.
46. Segreti J, Levin S. The role of prophylactic antibiotics in the prevention of prosthetic device infections. Infect Dis North Am 1989;3(2):357-70.
47. Segreti J. Is antibiotic prophylaxis necessary for prosthetic device infection? Infect Dis Clin North Am 1999 Dec;13(4):871-877 VII.
48. Poss R, Thormill TS, Ewald FC, Thomas WH, Batte NZ, Sledge CB. Factors influencing the incidence and outcone of infection following total joint arthroplasty. Clin Orthrop 1984;182:117-26.